The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Salvage lenvatinib/everolimus (LE) combination therapy after immune checkpoint inhibitor (ICI) and VEGFR tyrosine kinase inhibitor (TKI) for metastatic renal cell carcinoma (mRCC).
 
Adam Khorasanchi
No Relationships to Disclose
 
Christopher Kwok
No Relationships to Disclose
 
Sarah P. Psutka
Honoraria - AstraZeneca
Consulting or Advisory Role - Janssen; Merck
Travel, Accommodations, Expenses - medtronic
 
Megan Hinkley
No Relationships to Disclose
 
Shawn Dason
No Relationships to Disclose
 
Yuanquan (Aaron) Yang
Stock and Other Ownership Interests - Pfizer
Consulting or Advisory Role - The whiteoak group
Speakers' Bureau - AstraZeneca
Research Funding - Amgen (Inst); Incyte (Inst); Novartis (Inst)
 
Claire F. Verschraegen
Consulting or Advisory Role - CTI
 
Evan Gross
No Relationships to Disclose
 
Delaney Orcutt
No Relationships to Disclose
 
Ming Yin
Stock and Other Ownership Interests - Novavax